Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Dec 15, 2018; 10(12): 465-475
Published online Dec 15, 2018. doi: 10.4251/wjgo.v10.i12.465
Published online Dec 15, 2018. doi: 10.4251/wjgo.v10.i12.465
Histopathological factors | Risk of LNM | Management |
Depth of invasion in submucosa by the primary tumor of more than 1mm (Beaton et al[2]) | High | Surgery with lymph node dissection |
Poorly differentiated cancers (Beaton et al[2]) | ||
Tumor budding (Beaton et al[2], Sohn et al[18], Geramizadeh et al[7], Graham et al[22]) | ||
Lymphovascular invasion (Beaton et al[2]) | ||
Depth of invasion to the base of the stalk-Level 4 Haggitt (Nivatvongs et al[17], Kimura et al[19]) | ||
Submucosal invasion into the polyp stalk (Matsuda et al[16]) | ||
Micropapillary component (Sonoo et al[26], by Verdú et al[27], Mukai et al[28]) | ||
Head invasion (Kimura et al[19]) | Surgical resection with lymph node dissection in case of additional pathological risk factors | |
Head invasion (Kitajima et al[15], Matsuda et al[16]) | Low | Endoscopic polypectomy |
Depth of submucosal invasion/stalk invasion < 3000 μm (Kitajima et al[15]) | ||
Tumor size (Nivatvongs et al[17]) | ||
Grading (Nivatvongs et al[17]) | ||
Pseudoinvasion (Backes et al[13]) | Confirmation of t1 colorectal cancer by a second expert pathologist |
- Citation: Ciocalteu A, Gheonea DI, Saftoiu A, Streba L, Dragoescu NA, Tenea-Cojan TS. Current strategies for malignant pedunculated colorectal polyps. World J Gastrointest Oncol 2018; 10(12): 465-475
- URL: https://www.wjgnet.com/1948-5204/full/v10/i12/465.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i12.465